Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Top stocks for August

| The Motley Fool Staff

We asked our analysts to share their top stock picks for the coming month.

Read more »

Investing Articles

AstraZeneca plc’s shock plunge is a buying opportunity for the brave

| Harvey Jones

This could be the moment to buy AstraZeneca plc (LON: AZN) that you have been waiting for, says Harvey Jones.

Read more »

Investing Articles

Is AstraZeneca plc a falling knife to catch after dropping 15% today?

| Alan Oscroft

AstraZeneca plc (LON: AZN) could be one of best bargains of the FTSE 100 (INDEXFTSE: UKX) right now.

Read more »

Investing Articles

Why I’m considering FTSE 100 income and growth champion AstraZeneca plc

| Rupert Hargreaves

AstraZeneca plc (LSE: AZN) looks attractive to me today.

Read more »

Investing Articles

2 FTSE 100 stocks for retirement income AND growth

| G A Chester

These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver above-average income and strong capital growth.

Read more »

Investing Articles

2 FTSE 100 dividend stocks I’d buy in May

| Roland Head

Roland Head highlights two stocks with the potential for long-term income growth.

Read more »

Investing Articles

Does cancer breakthrough make this stock a better buy than AstraZenenca plc?

| Bilaal Mohamed

Should investors ditch AstraZeneca plc (LON:AZN) in favour of this promising AIM-listed biotech firm?

Read more »

Investing Articles

2 ‘evergreen’ Neil Woodford picks I’d buy now

| Kevin Godbold

These two stalwarts could power your portfolio for years to come.

Read more »

Investing Articles

2 FTSE 100 growth giants that could fund your retirement

| Alan Oscroft

These two rising FTSE 100 (INDEXFTSE:UKX) stocks could help you to a comfortable old age.

Read more »

Investing Articles

1 FTSE 100 stock I’d buy in April, and 1 I’d avoid

| Alan Oscroft

I'd rate these two as one of the best and one of the worst in the FTSE 100 (INDEXFTSE:UKX).

Read more »

Investing Articles

2 Neil Woodford stocks I’d buy in an instant

| Peter Stephens

These two Neil Woodford stocks could deliver high returns.

Read more »

Investing Articles

Is this top FTSE 100 income stock a clear takeover candidate?

| Rupert Hargreaves

Could this company find itself a takeover target once again?

Read more »